Trial Profile
The Effect of Intravitreal Aflibercept on Ocular Perfusion a Pilot Study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Mar 2017
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 10 Mar 2017 New trial record